ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1,3,Interleukin level increased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
1,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2,2,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2,3,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,6,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2,7,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,9,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2,10,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
2,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,13,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,14,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3,2,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3,3,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3,5,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
4,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4,4,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4,5,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4,7,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
4,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
5,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5,4,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
5,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5,6,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6,1,B-cell aplasia,Leukopenias NEC,White blood cell disorders,Blood,N
6,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
6,4,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
6,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6,6,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
7,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
9,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
9,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
10,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
10,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
10,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10,8,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
10,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
11,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
11,2,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
11,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
11,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
13,1,B-cell aplasia,Leukopenias NEC,White blood cell disorders,Blood,N
14,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
14,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
14,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
15,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
15,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
16,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
16,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
16,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
17,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
17,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
17,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
18,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
18,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
18,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
19,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
19,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
20,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
20,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
20,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
21,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
21,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
21,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
22,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
22,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
23,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
23,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
24,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
24,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
24,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
25,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
25,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
26,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
26,2,B-lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
26,3,Central nervous system leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
26,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
26,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
27,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
28,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
28,2,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
28,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
28,4,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
28,5,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
28,6,Headache,Headaches NEC,Headaches,Nerv,N
28,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
28,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
28,9,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
28,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
29,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
31,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
32,1,Blood lactate dehydrogenase decreased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
32,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
32,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
33,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
33,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
33,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
33,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
33,5,Polymerase chain reaction positive,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
34,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
35,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
36,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
36,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
36,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
36,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
36,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
38,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
38,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
39,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
39,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
39,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
40,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
41,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
42,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
42,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
42,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
42,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
42,5,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
42,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
42,7,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
42,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
42,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
42,10,Quadriparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
43,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
43,2,Cardiorenal syndrome,Heart failures NEC,Heart failures,Card,N
43,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
43,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
43,5,Dystonic tremor,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
43,6,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
43,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
43,8,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
43,9,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
43,10,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
43,11,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
43,12,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
43,13,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
43,14,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
43,15,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
43,16,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
43,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
43,18,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
43,19,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
44,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
44,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
44,3,Cardiorenal syndrome,Heart failures NEC,Heart failures,Card,N
44,4,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
44,5,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
44,6,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
44,7,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
44,8,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
44,9,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
44,10,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
44,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
44,12,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
44,13,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
44,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
44,15,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
44,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
45,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
46,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
46,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
46,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
47,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
48,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
48,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
49,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
50,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
51,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
52,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
52,2,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
52,3,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
52,4,Bone neoplasm,Bone neoplasms unspecified malignancy,Skeletal neoplasms malignant and unspecified,Neopl,N
52,5,Central nervous system neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
52,6,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,7,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
52,8,Loss of CAR T-cell persistence,Site specific procedural complications NEC,Procedural related injuries and complications NEC,Inj&P,N
52,9,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
53,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
53,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
54,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
54,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
55,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
55,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
56,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
56,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
56,3,Respiratory tract oedema,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
57,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
57,2,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
57,3,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
58,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
58,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
58,3,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
59,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
60,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
61,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
61,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
62,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
62,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
62,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
62,5,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
62,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
62,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
63,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
63,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
63,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
63,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
64,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
64,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
64,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
64,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
65,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
65,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
65,3,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
65,4,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
66,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
66,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
66,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
66,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
67,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
67,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
67,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
67,4,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
67,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
67,6,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
67,7,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
67,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
68,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
69,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
70,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
71,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
71,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
71,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
71,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
71,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
72,1,Allergic sinusitis,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
72,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
72,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
72,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
72,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
72,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
72,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
72,9,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
72,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
72,11,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
72,12,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
72,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,14,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
72,15,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
72,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
72,17,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
73,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
73,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
73,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
73,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
74,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
74,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
74,3,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
74,4,T-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
75,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
75,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
75,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
75,4,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
75,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
75,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
75,7,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
75,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
76,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
76,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
76,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
76,4,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
76,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
76,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
76,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
76,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
76,9,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
76,10,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
76,11,Pulse pressure increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
76,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
76,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
76,14,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
76,15,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
77,1,Loss of CAR T-cell persistence,Site specific procedural complications NEC,Procedural related injuries and complications NEC,Inj&P,N
78,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
79,1,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
79,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
79,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
79,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
79,5,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
80,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
81,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
82,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
82,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
83,1,Loss of CAR T-cell persistence,Site specific procedural complications NEC,Procedural related injuries and complications NEC,Inj&P,N
84,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
84,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
85,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
85,2,Immune effector cell encephalopathy score,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
86,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
87,1,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
88,1,Magnetic resonance imaging head,Central nervous system imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
89,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
90,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
91,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
92,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
93,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
94,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
94,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
94,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
94,4,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
94,5,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
94,6,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
94,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
94,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Diplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
95,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
95,3,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
95,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
95,5,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
95,6,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
95,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
95,8,Respiratory muscle weakness,Thoracic musculoskeletal disorders,Thoracic disorders (excl lung and pleura),Resp,N
96,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
98,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
